Martine Klausmann

Effects of recombinant human interleukin-3 in aplastic anemia

Arnold Ganser, A Lindemann, G. Seipelt et al. · Blood · 1990 · 123 citations · Full text

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b

Rudolf Weide, K. Ehlenz, W. Lorenz et al. · Annals of Hematology · 1996 · 73 citations

Bone Disease, Mast Cell Disorder, Immunology +3

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 48 citations · Full text

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 44 citations

Hematological Malignancy, Oncology, Transplantation +8